🎮 Learning games and sites · 🧩 Learning differences
EndeavorRx
By Akili, Inc. (agreed in 2024 to be bought by Virtual Therapeutics). Visit EndeavorRx
Desk research from the maker's own pages. Not yet tried by us. Checked 2026-10-24.
A prescription video game for children 8 to 17 with inattentive or combined-type ADHD, and the first game authorized by the FDA as a treatment (2020). The child steers a character through worlds while reacting to targets, about 25 minutes a day, five days a week, for at least four weeks, as the game adjusts its difficulty. A doctor must prescribe it; it is meant to go alongside therapy or medication, not replace them.
Our take: Worth asking your child's doctor about as one part of an ADHD plan; do not expect it to replace medication or therapy.
| Ages it suits | 8-17 with ADHD (prescription) |
|---|---|
| What its terms say about age | Prescription only, for the child it was prescribed to. The website terms say only adults over 18 may use the sites, so a parent handles sign-up and payment. (terms) |
| Price | Paid. $99 for a 30-day prescription, FSA/HSA eligible; needs a doctor's prescription (Oct 2026). |
| Works on | iPhone and iPad, Android |
| Account | A parent's account |
| Ads | None |
| In-app purchases | Yes |
| The AI in it | No generative AI; the game adjusts its challenge to the child's play. |
What's good
- FDA-authorized, tested in randomized trials
- Short daily sessions
- No serious side effects reported
Watch for
- Needs a prescription and costs $99 a month
- Proven gain is on an attention test, not always on behavior
- Some kids get frustrated or have headaches
- A 2024 deal agreed the company's sale; it collects health data
Data and privacy
Akili collects gameplay performance, ADHD questionnaires and other health-related data about the child. It says it does not knowingly sell or share data of under-16s and uses de-identified data for research and product work. Read the privacy policy.
Does it work?
A randomized controlled trial of 348 children aged 8 to 12 (Lancet Digital Health, 2020) found a small gain on a computer attention test versus a control game; it was sponsored by Akili and some authors work there. The FDA label warns it may not improve everyday symptoms such as hyperactivity.
In the Big Index
Alternatives to EndeavorRx
Desk researchFreeNo ads
Bookshare
Benetech (nonprofit) · ages all ages (PreK-12 students through adults)
A free, practical library for US students with a documented print disability; families without that need should use a public library app instead.
Desk researchPaidNo ads
C-Pen Reader
C-Pen (sold in the US by Scanning Pens) · ages school-age readers and adults
Worth a look for a child with dyslexia who reads paper books and worksheets; ask the school first, since many lend them.
Desk researchFree, with paid extras
Cboard
Cboard (Comunicacion Aumentativa Chile SpA) · ages all ages (children and adults who need AAC)
A low-cost way for families and therapists to try AAC on existing devices; families who need a fully supported, ad-free system funded through insurance may prefer a dedicated AAC product.
Desk researchFree, with paid extrasNo ads
Goblin Tools
Skyhook BV (Bram De Buyser) · ages about 10 and up (App Store rating 9+)
Helpful for teens who struggle to start tasks, ideally set up with a parent; younger kids need an adult using it with them.
Desk researchFree, with paid extras
Joon
Joon App, Inc. · ages 6-12
Worth a try for families of kids 6-12 who resist routines; parents can leave the AI voice off and judge results for themselves.
Desk researchPaidNo ads
Learning Ally
Learning Ally, Inc. (nonprofit) · ages grades PreK-12, plus college and adults
A strong choice for a child with dyslexia or a print disability who needs grade-level books; check first whether the school already provides it free.
Where these facts come from
- https://www.endeavorrx.com/
- https://www.endeavorrx.com/the-research/
- https://www.endeavorrx.com/faq/
- https://www.endeavorrx.com/getting-a-prescription/
- https://www.endeavorrx.com/instructions-for-use/
- https://www.akiliinteractive.com/terms-of-use
- https://www.akiliinteractive.com/privacy-notice
- https://doi.org/10.1016/S2589-7500(20)30017-0
- https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/denovo.cfm?id=DEN200026
- https://www.insidearbitrage.com/2024/05/virtual-therapeutics-set-to-acquire-akili-in-an-all-cash-deal/
Prices, terms and features change. Nobody paid to be listed, nothing here is an affiliate link, and Peabody never rates itself. Where we and the maker disagree, the maker's own pages are the ones to trust.